Subject | Sex | Age (years) | Medications | CRP (mg/l) | ESR (mm/hour) |
---|---|---|---|---|---|
RA Patients | |||||
RA-1aa | Male | 65 | None | 4.14b | 9 |
RA-1b | Male | 65 | MTX | 11.8 | 18 |
RA-2 | Female | 33 | Etanercept, naproxen | 25.7 | 18 |
RA-3 | Female | 43 | Etanercept | No data | No data |
RA-4 | Female | 45 | None | 98.4 | 84 |
RA-5 | Female | 55 | MTX | 4.8 | 26 |
RA-6 | Female | 73 | None | 2.1 | 30 |
RA-7 | Female | 51 | Hydroxychloroquine, MTX, prednisone | No data | 15 |
RA-8 | Male | 61 | Prednisone, MTX, hydroxychloroquine, sulfasalazine | No data | 1 |
RA-9 | Male | 46 | Methylprednisolone, MTX, etanercept | 2 | 9 |
RA-10 | Female | 32 | Leflunomide | 94.2 | 63 |
RA-11 | Female | 50 | Etanercept, MTX | No data | No data |
RA-12 | Male | 67 | MTX, celecoxib, prednisone | 0.6 | 11 |
RA-13 | Female | 55 | MTX | No data | 17 |
RA-14 | Female | 33 | Hydroxychloroquine, ibuprofen | 2.8 | 7 |
RA-15 | Female | 55 | None | 168.2 | 88 |
RA-16 | Female | 56 | Prednisone, minocycline | No data | No data |
Disease control individuals | |||||
SLE1 | Female | 36 | Hydroxychloroquine, prednisone, mycophenolate mofetil | ||
SjS1 | Female | 30 | Hydroxychloroquine, mycophenolate mofetil | ||
SjS2 | Male | 21 | Hydroxychloroquine | ||
SSc1 | Female | 57 | Cyclosporine, hydroxychloroquine, prednisone, mycophenolate mofetil |